SEC FORM 4
$349,591.25
Bicara Therapeutics Inc. (BCAX)
Sale of 12,500 shares at $27.9673 per share.
Reporting Person Hyep Ivan · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001470831-26-000814 · filed 2026-08-12 · View filing →